Cerebral Edema(complication ofrapidly decreasingBGL in HHSpatients (primarilyin the young)20 (# mEq of Kthat should beadded to eachliter withconcurrentinsulin infusion)LR (fluidchoiced forfasterresolution ofacidosis inDKA)6.5 (A1CDMdiagnosticcriteria)Infection (driverof DKA outsideof noncompliance andnew diagnosis)<6.9 (pH cutoff for routineadministrationof sodiumbicarb)320 (Totalserumomolarity cutoff for HHS)0.1 (units/kg/hrfor nonglucommanderDKA/HHS)Euglycemic(Type of DKAthat can be anadverse eventwith use ofSGLT2s)Basal(anotherterm for longactinginsulin)0.5(units/kg/day;recommendstarting dosefor new startinsulin)Fluids (mostimportant initialtreatment inhyperglycemicemergencies)1 (units/mL;standardconcentrationof IV insulininfusion)50 (averagemg/dL drop inBGL per 1unit rapidacting insulin)3.3 (mimimummEq/L K shouldbe prior toinitiated insulininfusion)IV (should only be usedfor patients withDKA/HHS/Hyperkalemia)Awiqli(newest FDAapprovedinsulin)<7.3 (pHcriteria forDKAdiagnosis)126(FastingBGL for DMdiagnosis)Kussmals(types ofrespirationsassociatedwith DKA)Polydipsia, polyphagia,polyuria (hallmarksymptoms ofuncontrolled/undiagnosedDM)600 (BGL levelwith HHS glucosediagnosticcriteria/max MHSglucommanderreading)Octerotide(medicationthat be usedin SU/insulinoverdose)BHG (replacedAG asdiagnosticcriteria in latestDKA/HHSguidelines)300 (BGL cutoff to startaddingdextrose tofluids in HHS)Lactic acidosis(possiblecomplication ofhallmark DMoral therapy)SQUID(protocol/trial thatsupported theaddition of SQinsulin in themagangement ofmild DKA)250 (BGL cutoff to startaddingdextrose tofluids in DKA)Cerebral Edema(complication ofrapidly decreasingBGL in HHSpatients (primarilyin the young)20 (# mEq of Kthat should beadded to eachliter withconcurrentinsulin infusion)LR (fluidchoiced forfasterresolution ofacidosis inDKA)6.5 (A1CDMdiagnosticcriteria)Infection (driverof DKA outsideof noncompliance andnew diagnosis)<6.9 (pH cutoff for routineadministrationof sodiumbicarb)320 (Totalserumomolarity cutoff for HHS)0.1 (units/kg/hrfor nonglucommanderDKA/HHS)Euglycemic(Type of DKAthat can be anadverse eventwith use ofSGLT2s)Basal(anotherterm for longactinginsulin)0.5(units/kg/day;recommendstarting dosefor new startinsulin)Fluids (mostimportant initialtreatment inhyperglycemicemergencies)1 (units/mL;standardconcentrationof IV insulininfusion)50 (averagemg/dL drop inBGL per 1unit rapidacting insulin)3.3 (mimimummEq/L K shouldbe prior toinitiated insulininfusion)IV (should only be usedfor patients withDKA/HHS/Hyperkalemia)Awiqli(newest FDAapprovedinsulin)<7.3 (pHcriteria forDKAdiagnosis)126(FastingBGL for DMdiagnosis)Kussmals(types ofrespirationsassociatedwith DKA)Polydipsia, polyphagia,polyuria (hallmarksymptoms ofuncontrolled/undiagnosedDM)600 (BGL levelwith HHS glucosediagnosticcriteria/max MHSglucommanderreading)Octerotide(medicationthat be usedin SU/insulinoverdose)BHG (replacedAG asdiagnosticcriteria in latestDKA/HHSguidelines)300 (BGL cutoff to startaddingdextrose tofluids in HHS)Lactic acidosis(possiblecomplication ofhallmark DMoral therapy)SQUID(protocol/trial thatsupported theaddition of SQinsulin in themagangement ofmild DKA)250 (BGL cutoff to startaddingdextrose tofluids in DKA)

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
  1. Cerebral Edema (complication of rapidly decreasing BGL in HHS patients (primarily in the young)
  2. 20 (# mEq of K that should be added to each liter with concurrent insulin infusion)
  3. LR (fluid choiced for faster resolution of acidosis in DKA)
  4. 6.5 (A1C DM diagnostic criteria)
  5. Infection (driver of DKA outside of non compliance and new diagnosis)
  6. <6.9 (pH cut off for routine administration of sodium bicarb)
  7. 320 (Total serum omolarity cut off for HHS)
  8. 0.1 (units/kg/hr for non glucommander DKA/HHS)
  9. Euglycemic (Type of DKA that can be an adverse event with use of SGLT2s)
  10. Basal (another term for long acting insulin)
  11. 0.5 (units/kg/day; recommend starting dose for new start insulin)
  12. Fluids (most important initial treatment in hyperglycemic emergencies)
  13. 1 (units/mL; standard concentration of IV insulin infusion)
  14. 50 (average mg/dL drop in BGL per 1 unit rapid acting insulin)
  15. 3.3 (mimimum mEq/L K should be prior to initiated insulin infusion)
  16. IV (should only be used for patients with DKA/HHS/Hyperkalemia)
  17. Awiqli (newest FDA approved insulin)
  18. <7.3 (pH criteria for DKA diagnosis)
  19. 126 (Fasting BGL for DM diagnosis)
  20. Kussmals (types of respirations associated with DKA)
  21. Polydipsia, polyphagia, polyuria (hallmark symptoms of uncontrolled/undiagnosed DM)
  22. 600 (BGL level with HHS glucose diagnostic criteria/max MHS glucommander reading)
  23. Octerotide (medication that be used in SU/insulin overdose)
  24. BHG (replaced AG as diagnostic criteria in latest DKA/HHS guidelines)
  25. 300 (BGL cut off to start adding dextrose to fluids in HHS)
  26. Lactic acidosis (possible complication of hallmark DM oral therapy)
  27. SQUID (protocol/trial that supported the addition of SQ insulin in the magangement of mild DKA)
  28. 250 (BGL cut off to start adding dextrose to fluids in DKA)